Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.06 USD
Change Today -0.01 / -0.14%
Volume 56.7K
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christian Weyer M.D., M.A.S.

Chief Executive Officer, President and Director, Fate Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 49 board members in 2 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Christian Weyer, also known as Chris, M.D., MAS-CLRE has been the Chief Executive Officer and President at Fate Therapeutics, Inc. since October 2012. Dr. Weyer served as Senior Vice President of Research & Development at Amylin Pharmaceuticals, Inc. since June 2010. He served as Vice President of Corporate Development - Diabetes & Obesity for Amylin Pharmaceuticals Inc. since August 2008. He joined Fate after a 12-year tenure with Amylin Pharmaceuticals, Inc. He ...

Read Full Background

Corporate Headquarters*

3535 General Atomics Court
San Diego, California 92121

United States

Phone: 858-875-1800
Fax: --

Board Members Memberships*

Chief Executive Officer, President and Director


Master's Degree
University of California - San Diego
University Of Düsseldorf

Other Affiliations*

Annual Compensation*

Total Annual Compensation$350,000

Stock Options*

Restricted Stock Awards$26,250
Exercisable Options321,050
Unexercisable Options423,241
Total Number of Options744,291

Total Compensation*

Total Annual Cash Compensation$428,750
Total Short Term Compensation$350,000
Other Long Term Compensation$26,250
Total Calculated Compensation$965,080
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FATE:US $7.06 USD -0.01


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FATE THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at